We therefore determined expression of Notch3 and GATA-3 in tissue samples from breast cancer patients with immunohistochemistry (IHC) (Fig. 6a–d) and explored their possible relationship with progesterone receptor (PR) and ER statuses, as well as their associations with other clinicopathologic features. This evidence concerns the gene GATA3 and breast carcinoma.